The Instructions for Use (IFU) Guides for our AIROS 6 and AIROS 8 Sequential Compression Devices are now available for Spanish-speaking patients.
Gerry Makoid, our president & CEO, appeared for interviews on Comcast’s “Money Matters” and RVNTV’s “The Advocates.” Topics discussed include the history of our company, business and manufacturing, and the healthcare conditions our products treat daily.
The Lymphatic Education & Research Network’s (LE&RN) newly-recognized Centers of Excellence, including a facility at the Children’s Hospital of Philadelphia (CHOP), have been recognized as leaders paving the way for the diagnosis and treatment of lymphatic disease.
AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy products that treat cancer-related lymphedema and venous complications, today announced the launch of its updated AIROS 6 Sequential Compression Therapy device and Arm Plus garments following multiple regulatory approvals.
Amidst the COVID-19 (Coronavirus) outbreak in the U.S. and across the world, we wanted to communicate information about precautions we are taking at AIROS Medical and provide an update about our business operations.
We will proudly present our device line at Medtrade Spring 2020 in Las Vegas next week. Medtrade is a conference that brings together Durable Medical Equipment/Home Medical Equipment companies, rehabilitation therapists, home health agencies and nurses, hospitals, and various other healthcare providers.
We are proud to announce that AIROS will again sponsor the annual “Run/Walk to Fight Lymphedema & Lymphatic Diseases,” presented by the Lymphatic Education & Research Network (LE&RN). Actor Kathy Bates is the national spokesperson for LE&RN.
AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy devices that treat cancer-related lymphedema as well as venous disorders, today announced it has received trademark registration from the United States Patent and Trademark Office (USPTO) for its company and brand name, “AIROS”.
Audubon, PA – January 13, 2020 – AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy devices that treat cancer-related lymphedema and venous complications, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its updated AIROS 8 Sequential Compression Therapy device and garment system.